Carotid intima media as a predictor of atherosclerotic disease in psoriasis patients
Keywords:
Psoriasis, Psoriatic Arthritis, Cardiovascular disease, Atherosclerosis.Abstract
Psoriasis is a chronic inflammatory skin disease, known as a multi-system disorder. A direct correlation between the thickness of the common carotid artery and the development of future cardiovascular complications has been described in patients with chronic inflammatory diseases. Some studies have shown a correlation of psoriasis and the development of cardiovascular events since they have an increased risk of developing atherosclerotic disease. In Venezuela, cardiovascular diseases are the leading cause of death, and despite the increasing number of patients with psoriasis, no studies have been carried out to determine the role of psoriasis and coronary artery disease. Therefore, the present investigation set out to determine the relationship between the degree of severity of psoriasis and the thickness of the carotid intima media in a group of 20 patients diagnosed with psoriasis. Once the information was collected, the chi-square test was performed, considering a statistically significant contrast if p <0.05. The data analysis was done with JMP-SAS version 12, obtaining as evidence that there is an association between the degree of severity of psoriasis and the thickness of the thickness of the carotid medial intima layer, so the existence of atherosclerotic disease could be predicted. subclinical.Downloads
References
Pandit VS, Palit A, Inamadar AC. A case-control study of frequency of occurrence of cardiovascular risk factors in patients with psoriasisJournal of Pakistan Association of Dermatologists. 2019; 29(4): 369-373.
Masson W, Lobo M, Molinero G. Psoriasis and Cardiovascular Risk: A Comprehensive Review. Adv Ther. 2020; 37, 2017–2033. https://doi.org/10.1007/s12325-020-01346-6
Ogdie A, McGill NK, Shin DB, Takeshita J, Love TJ, Noe MH, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. European Heart Journal. 2018; 39(39): 3608–3614. https://doi.org/10.1093/eurheartj/ehx145
National Psoriasis Foundation. [Internet]. Psoriasis statistics. [cited, 2019 april 6]. Disponible en: https://www.psoriasis.org/content/statistics#.
Kimball AB, Papp KA, Wasfi Y, Chan D, Bissonnette R, Sofen H, et al. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study. J Eur Acad Dermatol Venereol. 2013; 27:1535-1545. DOI: 10.1111/jdv.12046
- Kaiser H, Abdulla J, Henningsen KMA, Skov L, Hansen PR. Coronary Artery Disease Assessed by Computed Tomography in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Dermatology. 2019; 235:478–487. https://doi.org/10.1159/000502138
Parisi R, Iskandar IY, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020; 369 DOI: https://doi.org/10.1136/bmj.m1590.
- Masson W, Martín Lobo M, Molinero G. Psoriasis and Cardiovascular Risk: A Comprehensive Review. Advances in Therapy. 2020; 37:2017–2033.
Raaby L, Ahlehoff O, De Thurah A. Psoriasis and cardiovascular events: updating the evidence. Arch Dermatol Res.2017; 309, 225–228. https://doi.org/10.1007/s00403-016-1712-1.
Feldman SR, Hur P, Zhao Y, Tian H, Wei Z, Wang X, et al. Incidence rates of comorbidities among patients with psoriasis in the United States. Dermatol Online J. 2018; 24(10):13030/ DOI: qt2m18n6vj
Soriani Paschoal R, Antoniali Silva D, Nahas Cardili R, Da Silva Sousa C. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study. An. Bras. Dermatol. [Internet]. 2018 [cited 2020 July 18]; 93(2): 222-228. https://doi.org/10.1590/abd1806-4841.20186397.
Raikar SG, Neeli SI, Uppin VM, Uppin SM. Assessment of plasma homocysteine as a marker of acute renal injury in patients undergoing extracorporeal shock wave lithotripsy for renal stone disease - 1-year cross-sectional study. Indian J Health Sci Biomed Res. 2017 [cited July 18, 2020]; 10:34-40. Disponible en: http://www.ijournalhs.org on Saturday.
Pakolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among womwn. Br J Dermatol. 1994; 130:473-7 DOI: 10.1111/j.1365-2133. 1994.tb03380. x.
Raaby L, Ahlehoff O, De Thurah A. Psoriasis and cardiovascular events: updating the evidence. Arch Dermatol Res. 2017; 309, 225–228. https://doi.org/10.1007/s00403-016-1712-1.
Seleit I, Bakry OA, Abd El Gayed E, Ghanem M. Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphism in Psoriasis and Its Relation to Obesity, Metabolic Syndrome, and Narrowband Ultraviolet B Response: A Case-Control Study in Egyptian Patients. Indian J Dermatol. 2019; 64(3):192-200. DOI: 10.4103/ijd.IJD_114_18.
Huh JH, Lee JH, Moon JS, Sung KC, Kim JY, Kang DR. Metabolic Syndrome Severity Score in Korean Adults: Analysis of the 2010–2015 Korea National Health and Nutrition Examination Survey. J Korean Med Sci. 2019; 34(6): e48. https://doi.org/10.3346/jkms.2019.34.e48
Kim H-N, Han K, Song S-W, Lee JH. Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study. PLoS ONE 2018; 13(8): e0202854. https://doi.org/10.1371/journal.pone.0202854
Zhang Y, Zhao Y, Zhang T, Xu Q, He J. Cross-sectional associations between serum bilirubin and dyslipidemia in a population-based sample of Chinese. Int J Clin Exp Med 2016; 9(2): 4291-4299.
Pietrzak A, Chabros P, Grywalska E, Kiciński P, Pietrzak-Franciszkiewicz K, Krasowska D, et al. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update. Archives of medical science. 2019; 15(2), 369–375. https://doi.org/10.5114/aoms.2018.74021
Gundu HR. Cardiometabolic Diseases: A Global Perspective. J Cardiol & Cardiovasc Ther. 2018; 12(2): 555834. https://doi.org/10.19080/JOCCT.2018.12.555834.
Busso C, Lagodín C, Kotliar C, Forcada P, Olano D, Eimer L, et al. Identificación no invasiva de ateroesclerosis subclínica en individuos con psoriasis Dermatología Argentina. 2012; 18 (1): 44-51.
Información adicional
How to Cite
Issue
Section
License
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y construir a partir del material
- para cualquier propósito, incluso comercialmente.
Bajo los siguientes términos:
-
Atribución — Usted debe dar crédito de manera adecuada, brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
- No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.